Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
專家展望：禮來公司25位分析師的眼中
Across the recent three months, 25 analysts have shared their insights on Eli Lilly and Co (NYSE:LLY), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 18 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 4 | 9 | 0 | 0 | 0 |
| 2M Ago | 1 | 4 | 0 | 0 | 0 |
| 3M Ago | 2 | 4 | 0 | 0 | 0 |
Analysts have recently evaluated Eli Lilly and Co and provided 12-month price targets. The average target is $930.96, accompanied by a high estimate of $1025.00 and a low estimate of $840.00. This current average has increased by 4.14% from the previous average price target of $893.92.
Decoding Analyst Ratings: A Detailed Look
登入免費觀看全文
登入/註冊